MEI Pharma Inc ASCO Investor and Analyst Call Transcript
Good day, and welcome to the MEI Pharma ASCO 2021 Investor and Analyst Event. (Operator Instructions) Please also note that today's event is being recorded.
I would now like to turn the conference over to David Walsey, Senior Vice President, Corporate Affairs at MEI Pharma. Please go ahead, sir.
All right. Thank you. On our video webcast today, we will review data presented during e-poster sessions from the recently completed ASCO annual meeting regarding our drug candidate zandelisib. We will also review additional data and information related to the zandelisib program and provide a general update on our other programs.
Before we get started, I want to call your attention to the fact that this conference call may contain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in our forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |